Quantcast

Latest Diabetes management Stories

2014-10-23 12:29:18

Certification demonstrates Novo Nordisk's commitment to improving diabetes care PLAINSBORO, N.J., Oct. 23, 2014 /PRNewswire/ -- Novo Nordisk, a global leader in diabetes care, was honored with The National Committee for Quality Assurance (NCQA)'s Disease Management Certification in Program Design for its Diabetes Education Program (DEP) this month. The 2-year certification validates the DEP as a program providing quality educational support to both health care providers and patients...

2014-10-23 08:35:46

New Foods for Optimizing Diabetes Control Also Offer Healthier Options for People Seeking a Sweet Treat BOULDER, Colo., Oct. 23, 2014 /PRNewswire/ -- With National Diabetes Month just around the corner, LEVEL Life(TM), a modern diabetes management company focused on empowering people with the right tools to help manage their diabetes effectively, today announced the introduction of a new line of indulgent snacks, including Peanut Butter Cups and Peanut Turtle Bars that are formulated...

2014-10-22 23:09:29

ADW Diabetes announces on Wednesday that they have built a new diabetes educational email series for their newsletter subscribers. “Tune Into Diabetes” will be distributed for free on a monthly basis to all ADW Diabetes newsletter subscribers. Pompano Beach, FL (PRWEB) October 22, 2014 ADW Diabetes announces on Wednesday that they have built a new diabetes educational email series for their newsletter subscribers. “Tune Into Diabetes” will be distributed for free on a monthly...

2014-10-22 08:32:22

Demonstrates Proof-of-Concept for ORMD-0801 Oral Insulin to Reduce Exogenous Insulin Requirements JERUSALEM, October 22, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today reported positive top-line clinical results from its Phase IIa clinical trial of ORMD-0801, the company's proprietary oral insulin capsules, to treat type 1...

2014-10-22 08:32:13

Company launches The Diabetes Download, a new YouTube channel brought to you by Cornerstones4Care®, to help people living with diabetes incorporate better disease management into their lives. PLAINSBORO, N.J., Oct. 22, 2014 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced a new partnership with online sensation Michael Stevens, host and creator of the popular YouTube channel Vsauce, to launch a new 6-part video series, "Breaking Down Diabetes." Stevens, well known for...

2014-10-22 08:27:23

NEW YORK, Oct. 22, 2014 /PRNewswire/ -- Nuvilex, Inc. (OTCQB: NVLX) - According to the International Diabetes Federation, approximately 400 million people worldwide are living with diabetes, with that number expected to grow to 552 million people by 2030. The global market for diabetes treatments is approximately $500 billion. In 2012 approximately 330,000 people worldwide died from pancreatic cancer. Pancreatic cancer is the fourth most common cause of death due to cancer in...

2014-10-21 12:32:35

WORCESTER, Mass., Oct. 21, 2014 /PRNewswire/ -- Grove Instruments Inc., a medical device company based in Worcester, MA, developing the world's first noninvasive glucometer today announced that the Company has achieved a landmark clinical milestone known internally as "durable calibration." "This achievement was the last hurdle on the critical path to commercialization of our first product," explained Arthur Combs, Grove's CEO. "We have already identified our initial target markets...

2014-10-21 08:34:10

RIDGEFIELD, Conn. and INDIANAPOLIS, Oct. 21, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted the filing of a New Drug Application (NDA) for empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination, an investigational compound being studied for the treatment of adults with type 2 diabetes (T2D). Empagliflozin plus metformin is part of the Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) Diabetes alliance portfolio. "Type 2...

2014-10-21 08:33:10

Uppsala University Hospital in Sweden will enroll 8 patients in the study, partially supported by a recent grant by the JDRF ROSH HAAYIN, Israel, October 21, 2014 /PRNewswire/ -- Beta-O2 announced today that the first patient participating in the company's first broad study of the ssAir Bio-Artificial Pancreas has been successfully implanted. ssAir is in development as a treatment and a potential cure for type 1 diabetes (T1D). Approximately 3 million people have T1D in the...

2014-10-21 08:29:17

NEW YORK, Oct. 21, 2014 /PRNewswire/ -- Lazar Partners, a strategic communications firm for companies in the biopharma and medical device space, today announced the firm has been named the recipient of two PR Agency Elite awards by PR News for their work with partner Insulet Corporation on the diabetes blog, Suite D. Lazar Partners was nominated as a finalist and received honorable mention awards in both the Advocacy and Content Marketing categories. Winners were announced at PR...


Latest Diabetes management Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »
Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.